306515
Impact of the Patient Protection and Affordable Care Act (ACA) on Tobacco Cessation
Despite the promise of more accessible tobacco cessation opportunities, a lack of specificity in determining what falls under comprehensive tobacco cessation services allows for multiple standards of care. Preliminary studies have already reported a high degree of variation among health plans offered by states and individual insurers. Experts concur that unless the Department of Health and Human Services (HHS) specifies what kinds of tobacco cessation services should be covered, the opportunity to establish uniform, high-quality, and accessible tobacco cessation services will be lost.
Notwithstanding the present and future challenges to ACA tobacco cessation efforts, the law has set in motion significant transformation of the U.S. healthcare system, prompting states and corporations (i.e., CVS Caremark) to join the tobacco reform campaign. This presentation reports the most recent information on implications for tobacco cessation coverage under ACA guidelines, as obtained from extensive literature review of federal, state, and institutional reports, as well as reporting from various news channels, national conferences, and other subject matter experts.
Learning Areas:
Protection of the public in relation to communicable diseases including prevention or controlProvision of health care to the public
Public health or related laws, regulations, standards, or guidelines
Public health or related organizational policy, standards, or other guidelines
Public health or related public policy
Public health or related research
Learning Objectives:
Discuss the changes to Medicare, Medicaid, employer-sponsored insurance, and State Health Insurance Exchanges, as stipulated by the ACA.
List the major confounding factors that cause variability of tobacco cessation services.
Describe effective strategies for HHS to further define and specify tobacco cessation services.
Keyword(s): Tobacco Control, Affordable Care Act
Qualified on the content I am responsible for because: As CEO of Danya International, Inc., I provide overall strategic direction and leadership for all public health undertakings. I have more than 25 years of experience as an executive, clinician, researcher, and author on several federally funded research projects and more than 30 research articles and treatment manuals in a wide range of public health areas. Currently, I am interested in exploring the impact of the Affordable Care Act on coverage for tobacco cessation services.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.